Solaxa-H 100mg – Hydrocortisone Sodium Succinate Injection IP for IM or IV Use

600.00

Solaxa-H 100mg is a powerful injection for IM or IV use. It contains Hydrocortisone Sodium Succinate to reduce swelling and treat allergic reactions. Bioaxa, a trusted brand, makes this product to help you feel better quickly and safely.

Category:

Solaxa-H 100mg is a strong injection that doctors use through an IM (intramuscular) or IV (intravenous) method. It contains Hydrocortisone Sodium Succinate, which helps your body in many ways. First, it reduces swelling and pain caused by inflammation. Then, it calms down severe allergic reactions or immune system problems. As a result, this medicine works well for conditions like arthritis, allergic reactions, and certain autoimmune disorders.

For example, Solaxa-H 100mg can help with swelling in joints, skin reactions, or breathing issues from allergies. Bioaxa, a well-known company, makes this product with high quality and care. So, you can trust it for safe and effective relief. Each pack includes a 100mg vial of Solaxa-H powder, which a doctor or nurse mixes before use.

However, you should only use this injection under a doctor’s guidance. Your doctor will decide the right dose and method for you. In fact, Solaxa-H 100mg is a great choice if you need fast relief from swelling or allergic reactions. Order now to ensure you have a reliable solution for serious health issues!


Key Points

  • Powerful Medicine: Reduces swelling with Hydrocortisone Sodium Succinate.
  • For IM or IV Use: Doctors give it through a muscle or IV injection.
  • Treats Many Conditions: Helps with arthritis, allergies, and autoimmune issues.
  • Trusted Brand: Bioaxa ensures high quality and safety.
  • Pack Size: Comes in a 100mg vial for accurate dosing.
  • Doctor’s Supervision Needed: Use it only with a healthcare professional.

Reviews

There are no reviews yet.

Be the first to review “Solaxa-H 100mg – Hydrocortisone Sodium Succinate Injection IP for IM or IV Use”

Your email address will not be published. Required fields are marked *

Scroll to Top